ENTITY
Mayne Pharma

Mayne Pharma (MYX AU)

225
Analysis
Health Care • Australia
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
more
bullish•Santos Ltd
•22 Jun 2025 06:10

(Mostly) Asia-Pac M&A: Adriatic Metals, Carta, Mayne Pharma, PointsBet, Tourism Holdings

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
594 Views
Share
bearish•Mayne Pharma
•18 Jun 2025 15:53

Mayne Pharma (MYX AU): Entering Uncharted Territory as the Scheme Vote Passes

While Western case law burdens the buyer with establishing a MAC breach, the Mayne/Cosette court case wades into uncharted territory, bringing many...

Logo
672 Views
Share
bullish•Mayne Pharma
•18 Jun 2025 14:45

Mayne Pharma (MYX AU): The Vote Gets Up. Now What?

The possibility of an agreed price reduction has reduced; but arguably, so has the MAC threat. Only the facts presented during the court hearing...

Logo
675 Views
Share
bullish•Mayne Pharma
•16 Jun 2025 14:37

Mayne Pharma: No Precedence for a Deal Termination

Cosette signed a binding agreement to acquire Mayne Pharma (MYX) for $7.40 per share. Cosette, predictably got cold feet and is attempting to...

Logo
601 Views
Share
bearish•Mayne Pharma
•16 Jun 2025 01:23

Merger Arb Mondays (16 June) - Mayne, Pointsbet, Fengxiang, HKBN, Seven & I, Shibaura, Smartpay

We summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
1k Views
Share
x